Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01178 (
oxytocin
)
15,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The gene of prolactin-releasing peptide (PrRP) was first cloned in 1998 and preproproteins encoded by cDNAs produced at least two isoforms of PrRP with different lengths; PrRP31 and PrRP20. PrRP has been shown to release prolactin from the anterior pituitary at least in vitro (Hinuma, Y.S., Habata, Y., Fuji, R., Hosoya, M., Fukusumi, S., Kitada, C., Masuo, Y., Asano, T., Matsumoto, H., Sekiguchi, M., Kurokawa, T., Nishimura, O., Onda, H., and Fujino, A., 1998. A prolactin-releasing peptide in the brain. Nature 393, 272-6).
PrRP receptor
has also been detected by quantitive reverse transcription polymerase chain reaction, and in situ hybridization histochernistry revealed that expression of
PrRP receptor
mRNA was found in the broad areas of the brain and in the anterior pituitary of the rat. This review surveys morphological studies on PrRP, PrRP mRNA and
PrRP receptor
mRNA in the rat brain and discusses the possible functional significance of PrRP in the brain. PrRP immunoreactive neuronal perikarya showed a similar distributional pattern to those with PrRP mRNA signals. However, distribution of nerve processes and terminals with PrRP immunoreactivity was broadly expanded in the forebrain and brainstem. They were hardly detected in the median eminence particularly in its external layer.
PrRP receptor
mRNA signals were distributed in the preoptic area, and the hypothalamic area, where PrRP immunoreactive nerve processes and terminals were also detected. The strongest signal of
PrRP receptor
mRNA was detected in the reticular nucleus of the thalamus where neither PrRP immunoreactive nerve processes nor axon terminals were distributed. From the distribution pattern of PrRP and its receptor, it is suggested that PrRP is involved in control of secretion of
oxytocin
, corticotropin releasing hormone and somatostatin.
...
PMID:Morphological survey of prolactin-releasing peptide and its receptor with special reference to their functional roles in the brain. 1107 Jan 88
Food intake activates neurones expressing prolactin-releasing peptide (PrRP) in the medulla oblongata and
oxytocin
neurones in the hypothalamus. Both PrRP and
oxytocin
have been shown to have an anorexic action. In the present study, we investigated whether the activation of
oxytocin
neurones following food intake is mediated by PrRP. We first examined the expression of PrRP receptors (also known as
GPR10
) in rats. Immunoreactivity of PrRP receptors was observed in
oxytocin
neurones and in vasopressin neurones in the paraventricular and supraoptic nuclei of the hypothalamus and in the bed nucleus of the stria terminalis. Application of PrRP to isolated supraoptic nuclei facilitated the release of
oxytocin
and vasopressin. In mice, re-feeding increased the expression of Fos protein in
oxytocin
neurones of the hypothalamus and bed nucleus of the stria terminalis. The increased expression of Fos protein in
oxytocin
neurones following re-feeding or i.p. administration of cholecystokinin octapeptide (CCK), a peripheral satiety factor, was impaired in PrRP-deficient mice. CCK-induced
oxytocin
increase in plasma was also impaired in PrRP-deficient mice. Furthermore, oxytocin receptor-deficient mice showed an increased meal size, as reported in PrRP-deficient mice and in CCKA receptor-deficient mice. These findings suggest that PrRP mediates, at least in part, the activation of
oxytocin
neurones in response to food intake, and that the CCK-PrRP-
oxytocin
pathway plays an important role in the control of the termination of each meal.
...
PMID:Involvement of prolactin-releasing peptide in the activation of oxytocin neurones in response to food intake. 2336 38